Dale Broadrick - 08 Feb 2024 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
10%+ Owner
Signature
/s/ Dale Broadrick
Issuer symbol
BRTX
Transactions as of
08 Feb 2024
Net transactions value
+$206,023
Form type
4
Filing time
12 Feb 2024, 09:26:34 UTC
Previous filing
09 Feb 2024
Next filing
05 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Purchase $92,449 +73,959 +23% $1.25 391,931 08 Feb 2024 Ssee Footnote F1
transaction BRTX Common Stock Purchase $113,574 +86,041 +22% $1.32 477,972 09 Feb 2024 See Footnote F1
holding BRTX Common Stock 447,045 08 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Warrant to acquire Common Stock 250 08 Feb 2024 Common Stock 250 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 276 08 Feb 2024 Common Stock 276 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 833 08 Feb 2024 Common Stock 833 $120.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder.